Literature DB >> 9270431

Localization of transforming growth factor-beta-expressing cells and comparison with major extracellular components in aural cholesteatoma.

S Lang1, V Schilling, B Wollenberg, B Mack, A Nerlich.   

Abstract

Transforming growth factor-beta (TGF-beta) plays an important role in the regulation of extracellular matrix (ECM) deposition by stimulating the synthesis of individual matrix proteins like tenascin and fibronectin. Cholesteatoma shows significant changes in the ECM, supporting the view of a disturbed cell-matrix interaction. The purpose of our present study was to evaluate the distribution of TGF-beta in comparison to the deposition of tenascin, fibronectin, and collagen as major components of the ECM in cholesteatoma (n = 12) by means of histochemistry and immunohistochemistry. We found TGF-beta in lymphocytes and fibrohistiocytes in the stroma of 7 cholesteatomas. In corresponding sections, a marked expression of tenascin and fibronectin was seen manifesting as a continuous band along the epidermal-stromal junction, extending to the deeper stroma. In addition, in those cases of TGF-beta expression, beginning collagen fibril formation was seen in adjacent deeper stroma layers, indicating beginning stromal fibrosis. These results suggest that TGF-beta may be involved in the stimulation of the synthesis of tenascin, fibronectin, and collagen. Furthermore, the enhanced expression of tenascin and fibronectin provides evidence for a deregulated cell-matrix interaction in cholesteatoma associated with the enhanced proliferative process of cholesteatoma formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270431     DOI: 10.1177/000348949710600810

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

Review 1.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

2.  Continuous Microevolution Accelerates Disease Progression during Sequential Episodes of Infection.

Authors:  Alistair Harrison; Rachael L Hardison; Audra R Fullen; Rachel M Wallace; David M Gordon; Peter White; Ryan N Jennings; Sheryl S Justice; Kevin M Mason
Journal:  Cell Rep       Date:  2020-03-03       Impact factor: 9.423

Review 3.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

4.  Establishment and characterization of an in vitro model for cholesteatoma.

Authors:  Alexander M Raynov; Yun-Hoon Choung; Hun Yi Park; Seong Jun Choi; Keehyun Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-06-20       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.